Literature DB >> 18545744

Epidemiology and etiology of childhood pneumonia.

Igor Rudan1, Cynthia Boschi-Pinto, Zrinka Biloglav, Kim Mulholland, Harry Campbell.   

Abstract

Childhood pneumonia is the leading single cause of mortality in children aged less than 5 years. The incidence in this age group is estimated to be 0.29 episodes per child-year in developing and 0.05 episodes per child-year in developed countries. This translates into about 156 million new episodes each year worldwide, of which 151 million episodes are in the developing world. Most cases occur in India (43 million), China (21 million) and Pakistan (10 million), with additional high numbers in Bangladesh, Indonesia and Nigeria (6 million each). Of all community cases, 7-13% are severe enough to be life-threatening and require hospitalization. Substantial evidence revealed that the leading risk factors contributing to pneumonia incidence are lack of exclusive breastfeeding, undernutrition, indoor air pollution, low birth weight, crowding and lack of measles immunization. Pneumonia is responsible for about 19% of all deaths in children aged less than 5 years, of which more than 70% take place in sub-Saharan Africa and south-east Asia. Although based on limited available evidence, recent studies have identified Streptococcus pneumoniae, Haemophilus influenzae and respiratory syncytial virus as the main pathogens associated with childhood pneumonia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18545744      PMCID: PMC2647437          DOI: 10.2471/blt.07.048769

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  58 in total

1.  Relationship between acute respiratory infection and malnutrition in children under 5 years of age.

Authors:  A L Cunha
Journal:  Acta Paediatr       Date:  2000-05       Impact factor: 2.299

Review 2.  Nontyphoidal Salmonella infections of children in tropical Africa.

Authors:  S M Graham; E M Molyneux; A L Walsh; J S Cheesbrough; M E Molyneux; C A Hart
Journal:  Pediatr Infect Dis J       Date:  2000-12       Impact factor: 2.129

Review 3.  Respiratory syncytial virus epidemics: the ups and downs of a seasonal virus.

Authors:  Lone Graff Stensballe; Jayanth K Devasundaram; Eric A Simoes
Journal:  Pediatr Infect Dis J       Date:  2003-02       Impact factor: 2.129

Review 4.  Populations at risk for developing respiratory syncytial virus and risk factors for respiratory syncytial virus severity: infants with predisposing conditions.

Authors:  Leonard E Weisman
Journal:  Pediatr Infect Dis J       Date:  2003-02       Impact factor: 2.129

Review 5.  Selected populations at increased risk from respiratory syncytial virus infection.

Authors:  H Cody Meissner
Journal:  Pediatr Infect Dis J       Date:  2003-02       Impact factor: 2.129

6.  Clinical presentation of non-typhoidal Salmonella bacteraemia in Malawian children.

Authors:  S M Graham; A L Walsh; E M Molyneux; A J Phiri; M E Molyneux
Journal:  Trans R Soc Trop Med Hyg       Date:  2000 May-Jun       Impact factor: 2.184

7.  Molecular detection of respiratory syncytial virus in postmortem lung tissue samples from Mexican children deceased with pneumonia.

Authors:  M E Bustamante-Calvillo; F R Velázquez; L Cabrera-Munõz; J Torres; A Gómez-Delgado; J A Moreno; O Muñoz-Hernández
Journal:  Pediatr Infect Dis J       Date:  2001-05       Impact factor: 2.129

Review 8.  Estimates of world-wide distribution of child deaths from acute respiratory infections.

Authors:  Brian G Williams; Eleanor Gouws; Cynthia Boschi-Pinto; Jennifer Bryce; Christopher Dye
Journal:  Lancet Infect Dis       Date:  2002-01       Impact factor: 25.071

Review 9.  Predicting the distribution of under-five deaths by cause in countries without adequate vital registration systems.

Authors:  Saul S Morris; Robert E Black; Lana Tomaskovic
Journal:  Int J Epidemiol       Date:  2003-12       Impact factor: 7.196

10.  A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection.

Authors:  Keith P Klugman; Shabir A Madhi; Robin E Huebner; Robert Kohberger; Nontombi Mbelle; Nathaniel Pierce
Journal:  N Engl J Med       Date:  2003-10-02       Impact factor: 91.245

View more
  460 in total

1.  Polymorphism rs2239185 in vitamin D receptor gene is associated with severe community-acquired pneumonia of children in Chinese Han population: a case-control study.

Authors:  Wei Li; Linying Guo; Hongri Li; Chunrong Sun; Xiaodai Cui; Guowei Song; Jianhua Wang; Qi Zhang
Journal:  Eur J Pediatr       Date:  2014-11-01       Impact factor: 3.183

2.  Community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Haripur district, Pakistan: a cluster randomised trial.

Authors:  Abdul Bari; Salim Sadruddin; Attaullah Khan; Ibad ul Haque Khan; Amanullah Khan; Iqbal A Lehri; William B Macleod; Matthew P Fox; Donald M Thea; Shamim A Qazi
Journal:  Lancet       Date:  2011-11-10       Impact factor: 79.321

3.  Integrating pneumonia prevention and treatment interventions with immunization services in resource-poor countries.

Authors:  Adam L Cohen; Terri B Hyde; Jennifer Verani; Margaret Watkins
Journal:  Bull World Health Organ       Date:  2012-04-01       Impact factor: 9.408

4.  Design and initiation of a study to assess the direct and indirect effects of influenza vaccine given to children in rural India.

Authors:  Wayne Sullender; Karen Fowler; Anand Krishnan; Vivek Gupta; Lawrence H Moulton; Kathryn Lafond; Marc-Alain Widdowson; Renu B Lal; Shobha Broor
Journal:  Vaccine       Date:  2012-06-16       Impact factor: 3.641

5.  Community-based interventions for diarrhoeal diseases and acute respiratory infections in Nepal.

Authors:  Madhu Ghimire; Yasho Vardhan Pradhan; Mahesh Kumar Maskey
Journal:  Bull World Health Organ       Date:  2010-03       Impact factor: 9.408

6.  Agonist of growth hormone-releasing hormone reduces pneumolysin-induced pulmonary permeability edema.

Authors:  Rudolf Lucas; Supriya Sridhar; Ferenc G Rick; Boris Gorshkov; Nagavedi S Umapathy; Guang Yang; Aluya Oseghale; Alexander D Verin; Trinad Chakraborty; Michael A Matthay; Evgeny A Zemskov; Richard White; Norman L Block; Andrew V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

7.  Pneumonia's second wind? A case study of the global health network for childhood pneumonia.

Authors:  David Berlan
Journal:  Health Policy Plan       Date:  2015-10-05       Impact factor: 3.344

8.  Sialidase-based anti-influenza virus therapy protects against secondary pneumococcal infection.

Authors:  Maria Hedlund; Laura M Aschenbrenner; Kellie Jensen; Jeffrey L Larson; Fang Fang
Journal:  J Infect Dis       Date:  2010-04-01       Impact factor: 5.226

9.  Distance to health services affects local-level vaccine efficacy for pneumococcal conjugate vaccine (PCV) among rural Filipino children.

Authors:  Elisabeth Dowling Root; Marilla Lucero; Hanna Nohynek; Peter Anthamatten; Deborah S K Thomas; Veronica Tallo; Antti Tanskanen; Beatriz P Quiambao; Taneli Puumalainen; Socorro P Lupisan; Petri Ruutu; Erma Ladesma; Gail M Williams; Ian Riley; Eric A F Simões
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

10.  Cost-effectiveness of influenza vaccination in prior pneumonia patients in Israel.

Authors:  Dan Yamin; Ran D Balicer; Alison P Galvani
Journal:  Vaccine       Date:  2014-06-12       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.